Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.
PaperCitations, authors & open-access status
ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 37 citations, 2020 year and closed oa status.
37
Citations
2020
Year
closed
OA Status